RSV Vaccination Generates Strong Antibody Responses but Reduced Cellular Immunity in High-Risk Transplant Recipients
Time to read: 01:20. A single RSVpreF-based vaccine dose induced strong antibody and CD4 T-cell responses in solid organ transplant recipients, but cellular responses were significantly weaker in lung transplant recipients
Source: American Journal of Transplantation
Feature
Text
Progressive Pulmonary Fibrosis Carries a Prognosis Similar to IPF in Lung Transplant Candidates
Time to read: 01:15. Lung transplant candidates with progressive pulmonary fibrosis (PPF) had transplant-free survival and waiting-list mortality comparable to idiopathic pulmonary fibrosis (IPF).
Source: Respiratory Investigation
Text
Immunosuppression Optimisation in Older Kidney Transplant Recipients: Results from the OPTIMIZE Trial
Time to read: 01:15. Routine CNI minimisation with everolimus conferred no benefit over standard tacrolimus-MMF therapy in de novo kidney transplant recipients
Source: Journal of the American Society of Nephrology
Text
Donor Age and Outcomes After Unrelated Donor Transplantation in the Post-Transplant Cyclophosphamide Era
Time to read: 01:44. Posttransplant cyclophosphamide appears to mitigate the adverse impact of older unrelated donor age on survival, challenging the traditional priority for younger donors in allogeneic HCT.
Source: JAMA
Text
